Oncolytics Biotech, Inc. (ONCY)
0.4733
-0.08
(-15.03%)
USD |
NASDAQ |
Oct 12, 16:00
0.4553
-0.02
(-3.80%)
After-Hours: 06:51
Oncolytics Biotech Net Income (TTM) : -30.07M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -30.07M |
| March 31, 2026 | -25.90M |
| December 31, 2025 | -21.32M |
| September 30, 2025 | -18.92M |
| June 30, 2025 | -15.91M |
| March 31, 2025 | -15.84M |
| December 31, 2024 | -16.13M |
| September 30, 2024 | -19.93M |
| June 30, 2024 | -20.46M |
| March 31, 2024 | -20.79M |
| December 31, 2023 | -20.60M |
| September 30, 2023 | -24.00M |
| June 30, 2023 | -19.97M |
| March 31, 2023 | -18.42M |
| December 31, 2022 | -19.02M |
| September 30, 2022 | -18.86M |
| June 30, 2022 | -19.36M |
| March 31, 2022 | -21.27M |
| December 31, 2021 | -21.00M |
| September 30, 2021 | -22.01M |
| June 30, 2021 | -23.21M |
| March 31, 2021 | -22.23M |
| December 31, 2020 | -16.85M |
| September 30, 2020 | -24.39M |
| June 30, 2020 | -22.00M |
| Date | Value |
|---|---|
| March 31, 2020 | -21.00M |
| December 31, 2019 | -25.01M |
| September 30, 2019 | -13.96M |
| June 30, 2019 | -13.84M |
| March 31, 2019 | -13.18M |
| December 31, 2018 | -13.16M |
| September 30, 2018 | -13.24M |
| June 30, 2018 | -13.08M |
| March 31, 2018 | -13.06M |
| December 31, 2017 | -12.02M |
| September 30, 2017 | -12.19M |
| June 30, 2017 | -12.35M |
| March 31, 2017 | -11.12M |
| December 31, 2016 | -11.39M |
| September 30, 2016 | -10.10M |
| June 30, 2016 | -9.703M |
| March 31, 2016 | -10.83M |
| December 31, 2015 | -10.77M |
| September 30, 2015 | -11.48M |
| June 30, 2015 | -13.58M |
| March 31, 2015 | -14.78M |
| December 31, 2014 | -16.89M |
| September 30, 2014 | -19.08M |
| June 30, 2014 | -20.70M |
| March 31, 2014 | -21.28M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Sangamo Therapeutics, Inc. | -123.33M |
| Sarepta Therapeutics, Inc. | -266.10M |
| Anixa Biosciences, Inc. | -10.47M |
| Mera Pharmaceuticals, Inc. | -- |